You are here

Ortho Regenerative Technologies Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ORTH
CSE Index: 
Currency: 

Ortho RTi is an emerging Orthobiologics company dedicated to the development of novel therapeutic soft tissue repair technologies to dramatically improve the success rate of sports medicine surgeries. Our proprietary RESTORE technology platform, is a muco-adhesive CHITOSAN based biopolymer matrix, which in the case of Ortho-R, is mixed with patient conditioned plasma of a concentrate of proteins/growth factors (Platelet-Rich Plasma or “PRP”)  to deliver biologics to increase the healing rates of occupational and sports related injuries to tendons, meniscus, ligaments and cartilage. The polymer-biologics hybrid combination can be directly applied into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention. Considering the significant bioactivity and residency of our proprietary biopolymer, Ortho RTi continues to assess its potential for therapeutic uses outside of the soft tissue repair. Further information about Ortho RTi is available on the Company's website at www.orthorti.com and on SEDAR at www.sedar.com. Also follow us on LinkedIn and Twitter.

You are here

Ortho Regenerative Technologies Inc. (ORTH)

SEDAR Information

Company Info

Address
16667, Hymus Blvd.
Kirkland, QC H9H 4R9
Canada
Phone
514-782-0951
Fax
514-694-0865
Email
dumais@orthorti.com
Website
http://www.orthorti.com
Listing date
Tuesday, October 10, 2017
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Frederic Dumais
Email
dumais@orthorti.com
Auditor
Ernst & Young LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
24,752,424
Reserved for Issuance: 
6,018,826

Company Officers

Claude LeDuc, CEO

Bulletins

05/10/2017

2017-1003 – New Listing – Ortho Regenerative Technologies Inc. (ORTH)

le 5 octobre/October 2017

The common shares of Ortho Regenerative Technologies Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com.

Advertisement

Publicité

Latest CSE News

Upcoming Events

09-04_MJBizCon_INTL-Website

MJBizCon INT'L

Wednesday, September 4, 2019 (All day) to Friday, September 6, 2019 (All day)
09_10_The_Entrepreneurship_Society_Raising_Capital_Event_Website

The Entrepreneurship Society Raising Capital Conference

Tuesday, September 10, 2019 -
1:30pm to 5:30pm